Resolution-based distillation for efficient histology image classification

Artificial intelligence in digital pathology: a systematic review and meta-analysis of diagnostic test accuracy

Ensuring diagnostic performance of artificial intelligence (AI) before introduction into clinical practice is essential. Growing numbers of studies using AI for digital pathology have been reported over recent years. The aim of this work is to examine the diagnostic accuracy of AI in digital pathology images for any disease. This systematic review and meta-analysis included diagnostic accuracy studies using any type of AI applied to whole slide images (WSIs) for any disease. The reference standard was diagnosis by histopathological assessment and/or immunohistochemistry. Searches were conducted in PubMed, EMBASE and CENTRAL in June 2022. Risk of bias and concerns of applicability were assessed using the QUADAS-2 tool. Data extraction was conducted by two investigators and meta-analysis was performed using a bivariate random effects model, with additional subgroup analyses also performed. Of 2976 identified studies, 100 were included in the review and 48 in the meta-analysis. Studies were from a range of countries, including over 152,000 whole slide images (WSIs), representing many diseases. These studies reported a mean sensitivity of 96.3% (CI 94.1-97.7) and mean specificity of 93.3% (CI 90.5-95.4). There was heterogeneity in study design and 99% of studies identified for inclusion had at least one area at high or unclear risk of bias or applicability concerns. Details on selection of cases, division of model development and validation data and raw performance data were frequently ambiguous or missing. AI is reported as having high diagnostic accuracy in the reported areas but requires more rigorous evaluation of its performance.

The future of artificial intelligence in thoracic surgery for non-small cell lung cancer treatment a narrative review

Objectives

To present a comprehensive review of the current state of artificial intelligence (AI) applications in lung cancer management, spanning the preoperative, intraoperative, and postoperative phases.

Methods

A review of the literature was conducted using PubMed, EMBASE and Cochrane, including relevant studies between 2002 and 2023 to identify the latest research on artificial intelligence and lung cancer.

Conclusion

While AI holds promise in managing lung cancer, challenges exist. In the preoperative phase, AI can improve diagnostics and predict biomarkers, particularly in cases with limited biopsy materials. During surgery, AI provides real-time guidance. Postoperatively, AI assists in pathology assessment and predictive modeling. Challenges include interpretability issues, training limitations affecting model use and AI's ineffectiveness beyond classification. Overfitting and global generalization, along with high computational costs and ethical frameworks, pose hurdles. Addressing these challenges requires a careful approach, considering ethical, technical, and regulatory factors. Rigorous analysis, external validation, and a robust regulatory framework are crucial for responsible AI implementation in lung surgery, reflecting the evolving synergy between human expertise and technology.

Improving Representation Learning for Histopathologic Images with Cluster Constraints

Recent advances in whole-slide image (WSI) scanners and computational capabilities have significantly propelled the application of artificial intelligence in histopathology slide analysis. While these strides are promising, current supervised learning approaches for WSI analysis come with the challenge of exhaustively labeling high-resolution slides-a process that is both labor-intensive and timeconsuming. In contrast, self-supervised learning (SSL) pretraining strategies are emerging as a viable alternative, given that they don't rely on explicit data annotations. These SSL strategies are quickly bridging the performance disparity with their supervised counterparts. In this context, we introduce an SSL framework. This framework aims for transferable representation learning and semantically meaningful clustering by synergizing invariance loss and clustering loss in WSI analysis. Notably, our approach outperforms common SSL methods in downstream classification and clustering tasks, as evidenced by tests on the Camelyon16 and a pancreatic cancer dataset. The code and additional details are accessible at https://github.com/wwyi1828/CluSiam.

AI/ML advances in non-small cell lung cancer biomarker discovery

Lung cancer is the leading cause of cancer deaths among both men and women, representing approximately 25% of cancer fatalities each year. The treatment landscape for non-small cell lung cancer (NSCLC) is rapidly evolving due to the progress made in biomarker-driven targeted therapies. While advancements in targeted treatments have improved survival rates for NSCLC patients with actionable biomarkers, long-term survival remains low, with an overall 5-year relative survival rate below 20%. Artificial intelligence/machine learning (AI/ML) algorithms have shown promise in biomarker discovery, yet NSCLC-specific studies capturing the clinical challenges targeted and emerging patterns identified using AI/ML approaches are lacking. Here, we employed a text-mining approach and identified 215 studies that reported potential biomarkers of NSCLC using AI/ML algorithms. We catalogued these studies with respect to BEST (Biomarkers, EndpointS, and other Tools) biomarker sub-types and summarized emerging patterns and trends in AI/ML-driven NSCLC biomarker discovery. We anticipate that our comprehensive review will contribute to the current understanding of AI/ML advances in NSCLC biomarker research and provide an important catalogue that may facilitate clinical adoption of AI/ML-derived biomarkers.

RCKD: Response-Based Cross-Task Knowledge Distillation for Pathological Image Analysis

We propose a novel transfer learning framework for pathological image analysis, the Response-based Cross-task Knowledge Distillation (RCKD), which improves the performance of the model by pretraining it on a large unlabeled dataset guided by a high-performance teacher model. RCKD first pretrains a student model to predict the nuclei segmentation results of the teacher model for unlabeled pathological images, and then fine-tunes the pretrained model for the downstream tasks, such as organ cancer sub-type classification and cancer region segmentation, using relatively small target datasets. Unlike conventional knowledge distillation, RCKD does not require that the target tasks of the teacher and student models be the same. Moreover, unlike conventional transfer learning, RCKD can transfer knowledge between models with different architectures. In addition, we propose a lightweight architecture, the Convolutional neural network with Spatial Attention by Transformers (CSAT), for processing high-resolution pathological images with limited memory and computation. CSAT exhibited a top-1 accuracy of 78.6% on ImageNet with only 3M parameters and 1.08 G multiply-accumulate (MAC) operations. When pretrained by RCKD, CSAT exhibited average classification and segmentation accuracies of 94.2% and 0.673 mIoU on six pathological image datasets, which is 4% and 0.043 mIoU higher than EfficientNet-B0, and 7.4% and 0.006 mIoU higher than ConvNextV2-Atto pretrained on ImageNet, respectively.

PKDN: Prior Knowledge Distillation Network for bronchoscopy diagnosis

Bronchoscopy plays a crucial role in diagnosing and treating lung diseases. The deep learning-based diagnostic system for bronchoscopic images can assist physicians in accurately and efficiently diagnosing lung diseases, enabling patients to undergo timely pathological examinations and receive appropriate treatment. However, the existing diagnostic methods overlook the utilization of prior knowledge of medical images, and the limited feature extraction capability hinders precise focus on lesion regions, consequently affecting the overall diagnostic effectiveness. To address these challenges, this paper proposes a prior knowledge distillation network (PKDN) for identifying lung diseases through bronchoscopic images. The proposed method extracts color and edge features from lesion images using the prior knowledge guidance module, and subsequently enhances spatial and channel features by employing the dynamic spatial attention module and gated channel attention module, respectively. Finally, the extracted features undergo refinement and self-regulation through feature distillation. Furthermore, decoupled distillation is implemented to balance the importance of target and non-target class distillation, thereby enhancing the diagnostic performance of the network. The effectiveness of the proposed method is validated on the bronchoscopic dataset provided by Harbin Medical University Cancer Hospital, which consists of 2,029 bronchoscopic images from 200 patients. Experimental results demonstrate that the proposed method achieves an accuracy of 94.78% and an AUC of 98.17%, outperforming other methods significantly in diagnostic performance. These results indicate that the computer-aided diagnostic system based on PKDN provides satisfactory accuracy in diagnosing lung diseases during bronchoscopy.

Deep Learning for Lung Cancer Diagnosis, Prognosis and Prediction Using Histological and Cytological Images: A Systematic Review

Lung cancer is one of the deadliest cancers worldwide, with a high incidence rate, especially in tobacco smokers. Lung cancer accurate diagnosis is based on distinct histological patterns combined with molecular data for personalized treatment. Precise lung cancer classification from a single H&E slide can be challenging for a pathologist, requiring most of the time additional histochemical and special immunohistochemical stains for the final pathology report. According to WHO, small biopsy and cytology specimens are the available materials for about 70% of lung cancer patients with advanced-stage unresectable disease. Thus, the limited available diagnostic material necessitates its optimal management and processing for the completion of diagnosis and predictive testing according to the published guidelines. During the new era of Digital Pathology, Deep Learning offers the potential for lung cancer interpretation to assist pathologists' routine practice. Herein, we systematically review the current Artificial Intelligence-based approaches using histological and cytological images of lung cancer. Most of the published literature centered on the distinction between lung adenocarcinoma, lung squamous cell carcinoma, and small cell lung carcinoma, reflecting the realistic pathologist's routine. Furthermore, several studies developed algorithms for lung adenocarcinoma predominant architectural pattern determination, prognosis prediction, mutational status characterization, and PD-L1 expression status estimation.

Application of Artificial Intelligence in the Diagnosis, Treatment, and Prognostic Evaluation of Mediastinal Malignant Tumors

Artificial intelligence (AI), also known as machine intelligence, is widely utilized in the medical field, promoting medical advances. Malignant tumors are the critical focus of medical research and improvement of clinical diagnosis and treatment. Mediastinal malignancy is an important tumor that attracts increasing attention today due to the difficulties in treatment. Combined with artificial intelligence, challenges from drug discovery to survival improvement are constantly being overcome. This article reviews the progress of the use of AI in the diagnosis, treatment, and prognostic prospects of mediastinal malignant tumors based on current literature findings.

Self-supervised learning in medicine and healthcare

The development of medical applications of machine learning has required manual annotation of data, often by medical experts. Yet, the availability of large-scale unannotated data provides opportunities for the development of better machine-learning models. In this Review, we highlight self-supervised methods and models for use in medicine and healthcare, and discuss the advantages and limitations of their application to tasks involving electronic health records and datasets of medical images, bioelectrical signals, and sequences and structures of genes and proteins. We also discuss promising applications of self-supervised learning for the development of models leveraging multimodal datasets, and the challenges in collecting unbiased data for their training. Self-supervised learning may accelerate the development of medical artificial intelligence.

A Novel Approach to Classifying Breast Cancer Histopathology Biopsy Images Using Bilateral Knowledge Distillation and Label Smoothing Regularization

Breast cancer is the most common invasive cancer in women and the second main cause of cancer death in females, which can be classified benign or malignant. Research and prevention on breast cancer have attracted more concern of researchers in recent years. On the other hand, the development of data mining methods provides an effective way to extract more useful information from complex databases, and some prediction, classification, and clustering can be made according to the extracted information. The generic notion of knowledge distillation is that a network of higher capacity acts as a teacher and a network of lower capacity acts as a student. There are different pipelines of knowledge distillation known. However, previous work on knowledge distillation using label smoothing regularization produces experiments and results that break this general notion and prove that knowledge distillation also works when a student model distils a teacher model, i.e., reverse knowledge distillation. Not only this, but it is also proved that a poorly trained teacher model trains a student model to reach equivalent results. Building on the ideas from those works, we propose a novel bilateral knowledge distillation regime that enables multiple interactions between teacher and student models, i.e., teaching and distilling each other, eventually improving each other's performance and evaluating our results on BACH histopathology image dataset on breast cancer. The pretrained ResNeXt29 and MobileNetV2 models which are already tested on ImageNet dataset are used for "transfer learning" in our dataset, and we obtain a final accuracy of more than 96% using this novel approach of bilateral KD.